Malignant Peritoneal Neoplasm — Trials

Malignant Peritoneal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

502 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 124
Recruiting: 53
Ph III recruiting: 7
Growth YoY: —
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (75)

clinicaltrialsPublishedShowing 51–100 of 119 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01199263	Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer	completed	Phase 2	108	National Cancer Institute (NCI)NIH	1	Sep 16, 2020	clinicaltrials
NCT02151448	αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies	completed	Phase 1 / Phase 2	64	David BartlettOTHER	1	Jul 20, 2020